Target intelligence / Profile preview

B-cell lymphoma 2 protein family (BCL-2 family)

Target
BCL-2 family
Molecular classification
Apoptosis regulator, Protein family
01

Overview

The BCL-2 protein family is a group of evolutionarily related proteins that regulate apoptosis and the balance between cell survival and death. They control mitochondrial outer membrane permeability, a key step in intrinsic apoptosis. The family includes anti-apoptotic members (e.g., BCL-2, BCL-XL, MCL-1), pro-apoptotic multidomain members (e.g., Bax, Bak), and "BH3-only" proteins (e.g., BAD, BID). Dysregulation of BCL-2 family members, particularly overexpression of anti-apoptotic proteins, is implicated in cancer development and resistance to chemotherapy. Targeting these proteins with small-molecule inhibitors is an important strategy for developing new anticancer therapies.

Other names
BCL2 familyBcl-2 proteins
02

Mechanism of action

BH3 mimetics disrupt protein-protein interactions within the BCL-2 network, promoting apoptosis by antagonizing anti-apoptotic BCL-2 family members or directly activating Bax/Bak.

03

Biological functions

Regulation of apoptosisRegulation of mitochondrial outer membrane permeabilityCell survivalCell death
04

Disease associations

CancerHematological malignanciesLymphomaTumorigenesisResistance to chemotherapy
05

Safety considerations

On-target toxicity due to disruption of normal apoptotic processesDevelopment of resistance to BH3 mimeticsPotential for off-target effects
06

Interacting drugs

BH3 mimetics

1 more in the full profile.

07

Biomarkers

BCL-2 expression levels in tumor cellsRatio of pro-apoptotic to anti-apoptotic BCL-2 family members

Beyond the preview

Go deeper on B-cell lymphoma 2 protein family (BCL-2 family).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on B-cell lymphoma 2 protein family (BCL-2 family).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call